-77%

est. 2Y upside i

HealthcareSeries A

Scheduling and workforce management SaaS for home healthcare providers

Rank

#3179

Sector

Healthtech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Axle Health presents a risky equity opportunity with a weighted expected upside of 22%.

Last updated: March 10, 2026

Bull (17%)+200%

Axle Health successfully re-accelerates growth by expanding its AI-powered platform into new segments of the home health market and launching new generative AI patient engagement solutions, achieving 50%+ YoY growth. This drives revenue to $30M+ and justifies a $210M valuation (7x revenue) by 2028, leading to a favorable acquisition.

Base (48%)+30%

Axle Health maintains its niche in home health scheduling, growing steadily at ~15-20% YoY, reaching ~$15M revenue by 2028. It secures a modest acquisition at a slight premium to its current valuation, around $91M, providing a moderate return for common shareholders.

Bear (35%)-75%

Growth stalls due to intense competition from larger incumbents like Experian Health or new entrants, or the 'deadpooled' legal entity issue creates investor uncertainty. Revenue remains flat or declines, leading to a down round or distressed sale at $17.5M, wiping out most common stock value given the $14.3M in liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $14.3M in liquidation preferences ahead of common stock, representing 20.4% of the estimated $70M current valuation.

Dilution Risk

moderate

As a Series A company, Axle Health will likely require additional funding rounds, which will lead to further dilution of existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Axle Health's equity at this stage.

View all 2 open roles at Axle Health →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Axle Health's data — designed to show you've done your homework.

  • 1

    “The company reported 900% growth in FY2024, but the current projected growth is 9% YoY. Can you elaborate on the factors contributing to this shift and the strategy to re-accelerate growth in the next 12-24 months?”

  • 2

    “Given the 'deadpooled' status of a legal entity associated with Axle Health, how does the company assure employees and investors about its operational continuity and legal standing?”

  • 3

    “With large incumbents like Experian Health and the potential for EMR giants like Oracle Health (Cerner) or Epic to expand into scheduling and workforce management solutions, what specific strategies is Axle Health employing to defend its market position and proprietary technology?”

Community

Valuation Sentiment

Our model estimates -77% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.